ÉϺ£Êмζ¨Çø2019½ì¸ßÈýÓ¢ÓïÏÂѧÆÚÖÊÁ¿µ÷ÑÐ(¶þÄ£)ÊÔÌâ(º¬½âÎö) ÏÂÔØ±¾ÎÄ

ËûÃǵķ½ÑÔʱ¿ÉÄܱ˴ËÌý²»¶®£¬¼´Ê¹ËûÃÇÔÚ¸ÃÓïÑÔÖв»Í¬ºº×ֵķ¢Òô¿ÉÄܲ»Í¬£¬µ«ËûÃÇ¿ÉÄÜʹÓÃÏàͬµÄÊéÃæÓïÑÔ¡£mayΪÇé̬¶¯´Êºó½Ó¶¯´ÊÔ­ÐΡ£·ÖÎö¾äÒâ¿Õ´¦Ìîvary¡°±ä»¯¡±¡£¹ÊÌîC.

¡¾39ÌâÏê½â¡¿

¿¼²éÐÎÈÝ´Ê¡£¾äÒ⣺Éùµ÷ÊÇËùÓкºÓïµÄÒ»¸öÏÔÖøÌØÕ÷¡£distinguishing¡°ÓÐÇø±ðµÄ¡±ÎªÐÎÈÝ´ÊÐÞÊÎÃû´Êfeature¡£ÇÒ·ûºÏ¾äÒâ¡£¹ÊÌîK. ¡¾40ÌâÏê½â¡¿

¿¼²é¶¯´Ê¡£¾äÒ⣺ÔÚººÓïÖУ¬²»Í¬ºº×ÖÇ¿µ÷²»Í¬µÄÉùµ÷¡£¿Õ´¦È±ÉÙνÓï¡£·ÖÎö¾ä×Ó¿ÉÖª£¬±¾¾äΪһ°ãÏÖÔÚʱ¡£Ö÷ÓïΪdifferent words,ËùÒÔνÓïΪstress¡°Ç¿µ÷¡±£¬ÇÒ·ûºÏ¾äÒâ¡£¹ÊÌîJ.

III. Reading Comprehension Section A (15·Ö)

Directions: For each blank in the following passage there are four words or phrases marked A, B, C and D. Fill in each blank with the word or phrase that best fits the context.

When Elinor Ostrom won the Nobel Prize for her research on economic governance in 2009, it was the first (and so far, the only) time a woman won a Nobel for Economics. That prize has ___41___ for nearly 50 years. We don¡¯t do a great job of recognizing women¡¯s contributions to science and innovation. My colleagues and I wondered: Is one of the reasons why women are more likely to ___42___ science than men because they don¡¯t receive the same recognition?

To understand how ___43___ shapes women¡¯s motivation to remain in science, we first had to get a good measure of the motivations. We sought to first study a highly visible ___44___, prizes, because large prizes tend to be understood and appreciated by the broader public, and they also influence those who make decisions about scientific ___45___ and other financial support.

Our study focused on prizes in the biomedical sciences. If we¡¯re going to find ___46___ anywhere in science, it would be in this field. Women have entered biomedicine in equal numbers to men since the early 2000s. ___47___ this, of all Nobels awarded

to women, a full two-thirds have been for biomedical research. Our ___48___ was simple: we documented all biomedical research prizes we could find over the past five decades. We also considered the financial awards and importance associated with the prizes, as indicators of their ___49___. Then we measured the percentage of prizes won by women and the association between gender and prize quality.

Our initial results highlighted overall___50___ news: the proportion of biomedical prizes awarded to women has risen steadily. But when we looked at the association between gender and quality of prizes awarded, we observed a major difference: on average, women scientists win prizes associated with less money and importance than men do. Importantly, our further research suggests that there¡¯s no ___51___ that the quality or value of women-led research is any lower than that of men, as measured by citations (ÒýÓÃ) per article, productivity, or width of research topics studied. ___52___, women are catching up in terms of number of prizes won, but still fall significantly behind in regard to the importance and monetary awards associated with the prizes.

The bottom line: while on the surface it may appear that the gender gap has somewhat___53___ when it comes to science prizes, great injustice is hidden just below. The problem likely ___54___ beyond the borders of science. In business, for example, prizes and funding for new technology and innovation may follow a similar pattern, helping to explain the phenomenon observed for female entrepreneurs, again ___55___ by research. This is something worth examining in greater depth. 41. A. remained established 42. A. leave 43. A. contribution promotion 44. A. indicator compliment 45. A. experiments 46.

B. innovation

C. study

D. grants

B. substance

C. confirmation

D.

B. doubt B. recognition

C. question C. resolution

D. suspect D.

B. awarded

C. existed

D.

A. gender equality C. innovation patterns 47. A. In line with of

48. A. concept 49. A. improvement reputation 50. A. vague fundamental 51. A. description comparison 52. A. Therefore Nevertheless 53. A. highlighted 54. A. dominates justifies 55. A. turned out

B. taken on B. eliminated B. extends B. However B. evidence B. sudden B. outcome B. quality B. Contrary to

B. research prospects D. government control C. Compared with

D. In case

C. requirement C. accomplishment

D. approach D.

C. good D.

C. document D.

C. Instead D.

C. strengthened C. overtakes

D. narrowed D.

C. backed up D. held up

¡¾´ð°¸¡¿41. C 42. A 43. B 44. A 45. D 46. A 47. A 48. D 49. B 50. C 51. B 52. A 53. D 54. B 55. C ¡¾½âÎö¡¿

ÕâÊÇһƪÒéÂÛÎÄ¡£Åµ±´¶û¾­¼Ãѧ½±ÒѾ­´æÔÚ½ü50Ä꣬2009Ä꣬°£Àòŵ¡¤°ÂË¹ÌØÂÞÄ·ÒòÆä¾­¼ÃÖÎÀíÑо¿»ñµÃŵ±´¶û½±£¬ÕâÊǵÚÒ»´Îŵ±´¶û¾­¼Ãѧ½±ÓÉÅ®ÐÔ»ñµÃ¡£×÷ÕߺÜÏëÖªµÀÅ®ÐÔ±ÈÄÐÐÔ¸üÓпÉÄÜÀ뿪¿ÆÑ§½çµÄÔ­ÒòÖ®Ò»£¬ÊDz»ÊÇÒòΪËýÃÇûÓеõ½Í¬ÑùµÄÈÏ¿É?¶Ô´Ë×÷Õß½øÐÐÁËÑо¿µ÷²é£¬Ñо¿±íÃ÷£¬Å®ÐÔÖ÷µ¼µÄÑо¿µÄÖÊÁ¿»ò¼ÛÖµ²»µÍÓÚÄÐÐÔ£¬ÔÚ»ñ½±ÊýÁ¿·½Ã棬ŮÐÔÕýÔÚÓ­Í·¸ÏÉÏ£¬µ«ÔÚÖØÒªÐÔºÍÓë½±ÏîÏà¹ØµÄ½±½ð·½Ã棬¸¾Å®ÈÔÈ»´ó´óÂäºó¡£±íÃæÉÏ¿´£¬ÐÔ±ð²î¾àÔÚ¿ÆÑ§½±ÉÏÓÐËùËõС£¬µ«ÏÂÃæÒþ²Ø×ž޴óµÄ²»¹«Õý¡£ ¡¾41ÌâÏê½â¡¿

¿¼²é¶¯´Ê±æÎö¡£A. remainedÁôÏ£»B. awardedÊÚÓ裻C. existed´æÔÚ£»D. established½¨Á¢¡£¾äÒ⣺Õâ¸ö½±ÏîÒѾ­´æÔÚÁ˽«½ü50Äê¡£ÓÉǰÎÄ¿ÉÖª£¬2009Ä꣬°£Àòŵ¡¤°ÂË¹ÌØÂÞÄ·ÒòÆä¾­¼ÃÖÎÀíÑо¿»ñµÃŵ±´¶û½±£¬ÕâÊÇÒѾ­´æÔÚ½ü50Äêŵ±´¶û¾­¼Ãѧ½±£¬µÚÒ»´Îŵ±´¶û¾­¼Ãѧ½±

ÓÉÅ®ÐÔ»ñµÃ¡£ËùÒÔexist¡°´æÔÚ¡±·ûºÏ¾äÒâ¡£¹ÊCÑ¡ÏîÇÐÌâ¡£ ¡¾42ÌâÏê½â¡¿

¿¼²é¶¯´Ê±æÎö¡£A. leaveÀ뿪£»B. doubt»³ÒÉ£»C. question ѯÎÊ£»D. suspect»³ÒÉ¡£¾äÒ⣺ÎÒºÍÎÒµÄͬÊÂÃÇÏëÖªµÀ:Å®ÐÔ±ÈÄÐÐÔ¸üÓпÉÄÜÔ¶Àë¿ÆÑ§½çµÄÔ­ÒòÖ®Ò»£¬ÊDz»ÊÇÒòΪËýÃÇûÓеõ½Í¬ÑùµÄÈÏ¿É?¡£ÓÉ¡°because they don¡¯t receive the same recognition¡±ËýÃÇûÓеõ½Í¬ÑùµÄÈÏ¿É,ËùÒÔµ¼ÖÂËýÃÇÔ¶Àë¿ÆÑ§ÁìÓò¡£¹ÊAÑ¡ÏîÇÐÌâ¡£ ¡¾43ÌâÏê½â¡¿

¿¼²éÃû´Ê±æÎö¡£A. contribution¹±Ï×£»B. recognition ÈÏʶ£»C. resolution¾öÒ飻D. promotionÌáÉý¡£¾äÒ⣺ΪÁËÀí½âÈÏÖªÈçºÎËÜÔìÅ®ÐÔÁôÔÚ¿ÆÑ§ÁìÓòµÄ¶¯»ú£¬ÎÒÃÇÊ×ÏȱØÐë¶Ô¶¯»úÓÐÒ»¸öºÜºÃµÄºâÁ¿¡£ÓÉǰÎÄ¡°the same recognition¡±¿ÉÖª£¬×÷ÕߺÍ×÷ÕßµÄͬÊÂÃÇÏëÖªµÀ:Å®ÐÔ±ÈÄÐÐÔ¸üÓпÉÄÜÔ¶Àë¿ÆÑ§½çµÄÔ­ÒòÖ®Ò»£¬ÊDz»ÊÇÒòΪËýÃÇûÓеõ½Í¬ÑùµÄÈÏ¿É?£¬ËùÒÔ×÷ÕßÒªÑо¿ÈÏÖªÈçºÎËÜÔìÅ®ÐÔÁôÔÚ¿ÆÑ§ÁìÓòµÄ¶¯»ú¡£¹ÊBÑ¡ÏîÇÐÌâ¡£ ¡¾44ÌâÏê½â¡¿

¿¼²éÃû´Ê±æÎö¡£A. indicatorÖ¸±ê£»B. substanceÎïÖÊ£»C. confirmationÈ·¶¨£»D. complimentÔÞÃÀ¡£¾äÒ⣺ÎÒÃÇÊÔͼÊ×ÏÈÑо¿Ò»¸ö¸ß¶È¿É¼ûµÄÖ¸±ê¡ª¡ª½±Àø£¬ÒòΪ´óµÄ½±ÀøÍùÍù»á±»¸ü¹ã·ºµÄ¹«ÖÚËùÀí½âºÍÐÀÉÍ£¬¶øÇÒËüÃÇÒ²»áÓ°ÏìÄÇЩ¾ö¶¨¿ÆÑ§×ÊÖúºÍÆäËû²ÆÕþÖ§³ÖµÄÈË¡£½±ÀøÊÇÑо¿µÄÒ»¸öÖ¸±ê£¬ÒÔ¼°ÏÂÎÄ¡°indicators of their quality¡±ÖÊÁ¿Ö¸±ê£¬¿ÉÒÔÅжϳöindicator·ûºÏ¾äÒâ¡£¹ÊAÑ¡ÏîÇÐÌâ¡£ ¡¾45ÌâÏê½â¡¿

¿¼²éÃû´Ê±æÎö¡£A. experimentsʵÑ飻B. innovation ¸ïУ»C. studyÑо¿£»D. grants²¦¿î¡£¾äÒ⣺ÎÒÃÇÊÔͼÊ×ÏÈÑо¿Ò»¸ö¸ß¶È¿É¼ûµÄÖ¸±ê¡ª¡ª½±Àø£¬ÒòΪ´óµÄ½±ÀøÍùÍù»á±»¸ü¹ã·ºµÄ¹«ÖÚËùÀí½âºÍÐÀÉÍ£¬¶øÇÒËüÃÇÒ²»áÓ°ÏìÄÇЩ¾ö¶¨¿ÆÑ§×ÊÖúºÍÆäËû²ÆÕþÖ§³ÖµÄÈË¡£ÓÉ¡° other financial support.¡±¿ÉÖª£¬and²¢ÁÐÁ¬½ÓµÄÊǾö¶¨¿ÆÑ§×ÊÖúºÍÆäËû²ÆÕþÖ§³ÖµÄÈË¡£¹ÊDÑ¡ÏîÇÐÌâ¡£ ¡¾46ÌâÏê½â¡¿

¿¼²éÃû´Ê¶ÌÓï±æÎö¡£A. gender equalityÐÔ±ðÆ½µÈ£»B. research prospects Ñо¿Ç°¾°£»C. innovation patterns ´´ÐÂģʽ£»D. government control Õþ¸®¿ØÖÆ¡£¾äÒ⣺Èç¹ûÎÒÃÇÒªÔÚ¿ÆÑ§ÁìÓòÕÒµ½ÐÔ±ðÆ½µÈ£¬ÄÇÒ»¶¨ÊÇÔÚÕâ¸öÁìÓò¡£ÓÉÏÂÎÄ¡°Women have entered biomedicine in equal numbers to men since the early 2000s.¡±¿ÉÖª21ÊÀ¼Í³õÒÔÀ´£¬Å®ÐÔ½øÈëÉúÎïҽѧÁìÓòµÄÈËÊýÓëÄÐÐÔ³ÖÆ½¡£ËùÒÔÈç¹ûÎÒÃÇÒªÔÚ¿ÆÑ§ÁìÓòÕÒµ½ÐÔ±ðÆ½µÈ£¬ÄÇÒ»¶¨ÊÇÔÚÕâ¸öÁìÓò¡£